SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086913
Filing Date
2023-11-14
Accepted
2023-11-14 16:06:22
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_adialpharma.htm   iXBRL 10-Q 582817
2 CERTIFICATION f10q0923ex31-1_adialpharma.htm EX-31.1 12220
3 CERTIFICATION f10q0923ex31-2_adialpharma.htm EX-31.2 12729
4 CERTIFICATION f10q0923ex32-1_adialpharma.htm EX-32.1 4717
5 CERTIFICATION f10q0923ex32-2_adialpharma.htm EX-32.2 4620
  Complete submission text file 0001213900-23-086913.txt   4204519

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20230930.xsd EX-101.SCH 48906
7 XBRL CALCULATION FILE adil-20230930_cal.xml EX-101.CAL 36153
8 XBRL DEFINITION FILE adil-20230930_def.xml EX-101.DEF 230115
9 XBRL LABEL FILE adil-20230930_lab.xml EX-101.LAB 461624
10 XBRL PRESENTATION FILE adil-20230930_pre.xml EX-101.PRE 243770
53 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_adialpharma_htm.xml XML 410904
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 231405975
SIC: 2834 Pharmaceutical Preparations